Rhythm HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology Share by Ken Dropiewski on March 7, 2024 More in Rhythm: Abbott’s Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation December 22, 2025 ZOLL Launches Fifth-Generation LifeVest® WCD December 19, 2025 Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation December 18, 2025 Share this story Facebook Twitter LinkedIn SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology